Eagle Pharma Outsourcing Recalls Infusions Due to Sterility Concerns
Eagle Pharma Outsourcing LLC is recalling phenylephrine HCL and oxytocin infusions nationwide due to a lack of assurance of sterility.
Eagle Pharma Outsourcing LLC has issued a recall for two infusion products: PHENYLephrine HCL Infusion and Oxytocin in sodium chloride.
The recall was initiated due to a lack of assurance of sterility. Compromised sterility in injectable drug products can pose serious health risks to patients.
The products were distributed nationwide within the U.S. The U.S. Food and Drug Administration is monitoring this Class II recall.
What to do
- Immediately stop using and administering the affected infusion products.
- Quarantine any remaining inventory to prevent further distribution or administration.
- Contact Eagle Pharma Outsourcing LLC or the FDA for questions and further instructions.
At a glance
| Agency | U.S. Food and Drug Administration (FDA) |
|---|---|
| Recall numbers | D-0105-2027, D-0106-2027 |
| Date | 2026-11-04 |
| Company | Eagle Pharma Outsourcing LLC, Hoover, AL |
| Severity | Class II |
| Quantity | 50 250 mL-containers; 5 500-mL containers |
| Where sold | Nationwide within the U.S |
| Lot codes / identifiers | Lot: PHENYL100-1004, Expiry: 12/31/2026.; Lot: OXY30-1006, Expiry: 10/10/2026. |
Recalled products
- PHENYLephrine HCL Infusion, 100 mg per 250 mL in 0.9% Sodium Chloride (0.4 mg/mL), Sterile, Rx Only, Single-Use Container, EAGLE PHARMA OUTSOURCING, 2200 Riverchase Center, Suite 675, Hoover, AL 35244, UPC: 6985210025. NDC 69852-100-25
- OXYTOCIN, 30 USP UNITS, Added to 0.9% Sodium Chloride 500 mL – Single-Use Container, Rx Only, EAGLE PHARMA OUTSOURCING, 2200 Riverchase Center, Suite 675, Hoover, AL 35244, UPC: 6985203050. NDC 69852-030-50
Source: official FDA notice. This summary was written by 365 News from the official notice. Details can change; check the notice before acting.